Psp Research LLC Top Holdings and 13F Report (2026) About Psp Research LLCInvestment ActivityPsp Research LLC has $145.83 million in total holdings as of September 30, 2026.Psp Research LLC owns shares of 44 different stocks, but just 2 companies or ETFs make up 80% of its holdings.Approximately 3.43% of the portfolio was purchased this quarter.About 31.52% of the portfolio was sold this quarter.This quarter, Psp Research LLC has purchased 75 new stocks and bought additional shares in 0 stocks.Psp Research LLC sold shares of 27 stocks and completely divested from 32 stocks this quarter.Largest Holdings ISHARES TR $70,476,000SPDR S&P Biotech ETF $60,943,320Sera Prognostics $5,009,072Halozyme Therapeutics $331,200Madrigal Pharmaceuticals $302,376 Largest New Holdings this Quarter 81749D107 - Sera Prognostics $5,009,072 Holding Largest Purchases this Quarter Sera Prognostics 2,396,685 shares (about $5.01M) Largest Sales this Quarter SPDR S&P Biotech ETF 183,500 shares (about $28.93M)Halozyme Therapeutics 4,000 shares (about $441.60K)Incyte 3,300 shares (about $400.46K)Royalty Pharma 6,000 shares (about $350.16K)argenex 341 shares (about $326.99K) Sector Allocation Over TimeMap of 500 Largest Holdings ofPsp Research LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorISHARES TR$70,476,0000.0%700,00048.3%0-3 MTH TREASURYXBISPDR S&P Biotech ETF$60,943,320$28,934,280 ▼-32.2%386,50041.8%ETFSERASera Prognostics$5,009,072$5,009,072 ▲New Holding2,396,6853.4%HealthcareHALOHalozyme Therapeutics$331,200$441,600 ▼-57.1%3,0000.2%HealthcareMDGLMadrigal Pharmaceuticals$302,3760.0%6000.2%HealthcareEXELExelixis$292,050$175,230 ▼-37.5%5,0000.2%HealthcareRPRXRoyalty Pharma$291,800$350,160 ▼-54.5%5,0000.2%HealthcareARGXargenex$287,673$326,988 ▼-53.2%3000.2%HealthcareNRIXNurix Therapeutics$284,520$308,230 ▼-52.0%12,0000.2%HealthcareTGTXTG Therapeutics$278,900$278,900 ▼-50.0%5,0000.2%HealthcareTARSTarsus Pharmaceuticals$275,135$275,135 ▼-50.0%3,5000.2%HealthcareHRMYHarmony Biosciences$274,820$117,780 ▼-30.0%7,0000.2%HealthcareARQTArcutis Biotherapeutics$264,300$256,371 ▼-49.2%10,0000.2%HealthcareKINIKSA PHARMACEUTICALS INTL$261,135$111,915 ▼-30.0%3,5000.2%ORD SHS CL ASUPNSupernus Pharmaceuticals$258,2400.0%6,0000.2%HealthcareIMNMImmunome$258,120$129,060 ▼-33.3%12,0000.2%HealthcareNBIXNeurocrine Biosciences$255,312$170,208 ▼-40.0%1,8000.2%HealthcareORUKA THERAPEUTICS INC$249,8700.0%3,0000.2%COMTNGXTango Therapeutics$249,5000.0%10,0000.2%HealthcareDEFINIUM THERAPEUTICS INC$247,390$133,210 ▼-35.0%6,5000.2%COM SHSRVMDRevolution Medicines$246,3120.0%1,2000.2%HealthcareALKSAlkermes$243,1200.0%6,0000.2%HealthcareAUPHAurinia Pharmaceuticals$242,925$242,925 ▼-50.0%15,0000.2%HealthcareINCYIncyte$242,700$400,455 ▼-62.3%2,0000.2%HealthcareNTLAIntellia Therapeutics$241,2000.0%20,0000.2%HealthcareIMVTImmunovant$236,460$202,680 ▼-46.2%7,0000.2%HealthcareSTOKStoke Therapeutics$234,000$78,000 ▼-25.0%9,0000.2%HealthcareKRYSKrystal Biotech$230,1320.0%6920.2%HealthcareASCENDIS PHARMA A/S$227,830$113,915 ▼-33.3%1,0000.2%ORD SHSSNDXSyndax Pharmaceuticals$225,600$150,400 ▼-40.0%12,0000.2%HealthcareKYMRKymera Therapeutics$223,580$223,580 ▼-50.0%2,0000.2%HealthcareDIANTHUS THERAPEUTICS INC$220,1250.0%2,5000.2%COMTRVITrevi Therapeutics$214,800$214,800 ▼-50.0%15,0000.1%HealthcareMIRMMirum Pharmaceuticals$213,7000.0%2,5000.1%HealthcareIMCRImmunocore$212,030$246,591 ▼-53.8%7,0000.1%HealthcarePTGXProtagonist Therapeutics$211,335$211,335 ▼-50.0%1,5000.1%HealthcareEWTXEdgewise Therapeutics$203,0000.0%5,0000.1%HealthcareORICOric Pharmaceuticals$175,1100.0%13,0000.1%HealthcareDYNE THERAPEUTICS INC$161,100$161,100 ▼-50.0%10,0000.1%COMCMPSCompass Pathways$124,400$99,520 ▼-44.4%10,0000.1%HealthcareOCULOcular Therapeutix$115,0500.0%15,0000.1%HealthcareCTMXCytomX Therapeutics$107,1680.0%39,4000.1%HealthcareARDXArdelyx$102,600$102,600 ▼-50.0%30,0000.1%HealthcareOLMAOlema Pharmaceuticals$86,4000.0%10,0000.1%HealthcareIRONDisc Medicine$0$585,120 ▼-100.0%00.0%HealthcareRAPPORT THERAPEUTICS INC$0$583,380 ▼-100.0%00.0%COMRAREUltragenyx Pharmaceutical$0$567,630 ▼-100.0%00.0%HealthcareGLUEMonte Rosa Therapeutics$0$556,600 ▼-100.0%00.0%HealthcareIONSIonis Pharmaceuticals$0$539,172 ▼-100.0%00.0%HealthcarePHVSPharvaris$0$518,700 ▼-100.0%00.0%HealthcareACADACADIA Pharmaceuticals$0$500,080 ▼-100.0%00.0%HealthcarePTCTPTC Therapeutics$0$489,420 ▼-100.0%00.0%HealthcareCLDXCelldex Therapeutics$0$483,730 ▼-100.0%00.0%HealthcareCOGTCogent Biosciences$0$464,400 ▼-100.0%00.0%HealthcareALNYAlnylam Pharmaceuticals$0$441,009 ▼-100.0%00.0%HealthcareCRNXCrinetics Pharmaceuticals$0$411,620 ▼-100.0%00.0%HealthcareNAMSNewAmsterdam Pharma$0$406,680 ▼-100.0%00.0%HealthcareLQDALiquidia$0$398,650 ▼-100.0%00.0%HealthcareVKTXViking Therapeutics$0$390,100 ▼-100.0%00.0%HealthcareELVNEnliven Therapeutics$0$355,250 ▼-100.0%00.0%HealthcareSPYRE THERAPEUTICS INC$0$355,120 ▼-100.0%00.0%COM NEWVERAVera Therapeutics$0$300,370 ▼-100.0%00.0%HealthcareCRSPCRISPR Therapeutics$0$272,700 ▼-100.0%00.0%HealthcareZYMEWORKS INC$0$261,400 ▼-100.0%00.0%COMXENEXenon Pharmaceuticals$0$253,512 ▼-100.0%00.0%HealthcareAXSMAxsome Therapeutics$0$244,770 ▼-100.0%00.0%HealthcareARRIVENT BIOPHARMA INC$0$244,604 ▼-100.0%00.0%COMJAZZJazz Pharmaceuticals$0$233,982 ▼-100.0%00.0%HealthcareKODKodiak Sciences$0$233,760 ▼-100.0%00.0%HealthcareBBIOBridgeBio Pharma$0$223,440 ▼-100.0%00.0%HealthcareRYTMRhythm Pharmaceuticals$0$222,060 ▼-100.0%00.0%HealthcareDNLIDenali Therapeutics$0$217,668 ▼-100.0%00.0%HealthcareARWRArrowhead Pharmaceuticals$0$211,926 ▼-100.0%00.0%HealthcareSRRKScholar Rock$0$210,485 ▼-100.0%00.0%HealthcareAMLXAmylyx Pharmaceuticals$0$194,650 ▼-100.0%00.0%HealthcareEYPTEyepoint Pharmaceuticals$0$143,000 ▼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
